Erythropoietin	B:C0014822
activates	O
SIRT1	O
to	O
protect	O
human	O
cardiomyocytes	O
against	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
dysfunction	I:C4021734
and	O
toxicity	O
.	O

Erythropoietin	O
activates	O
SIRT1	B:C1101544
to	O
protect	O
human	O
cardiomyocytes	O
against	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
dysfunction	I:C4021734
and	O
toxicity	O
.	O

Erythropoietin	O
activates	O
SIRT1	O
to	O
protect	O
human	B:C0086418
cardiomyocytes	O
against	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
dysfunction	I:C4021734
and	O
toxicity	O
.	O

Erythropoietin	O
activates	O
SIRT1	O
to	O
protect	O
human	O
cardiomyocytes	B:C0225828
against	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
dysfunction	I:C4021734
and	O
toxicity	O
.	O

Erythropoietin	O
activates	O
SIRT1	O
to	O
protect	O
human	O
cardiomyocytes	O
against	O
doxorubicin	B:C0013089
-	O
induced	O
mitochondrial	O
dysfunction	I:C4021734
and	O
toxicity	O
.	O

Erythropoietin	O
activates	O
SIRT1	O
to	O
protect	O
human	O
cardiomyocytes	O
against	O
doxorubicin	O
-	O
induced	O
mitochondrial	B:C4021734
dysfunction	I:C4021734
and	O
toxicity	O
.	O

Erythropoietin	O
activates	O
SIRT1	O
to	O
protect	O
human	O
cardiomyocytes	O
against	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
dysfunction	I:C4021734
and	O
toxicity	B:C0600688
.	O

The	O
hormone	B:C0019932
erythropoietin	O
(	O
erythropoietin	O
)	O
has	O
been	O
demonstrated	O
to	O
protect	O
against	O
chemotherapy	O
drug	O
doxorubicin	O
(	O
doxorubicin	O
)	O
-	O
induced	O
cardiotoxicity	O
,	O
but	O
the	O
underlying	O
mechanism	O
remains	O
obscure	O
.	O

The	O
hormone	O
erythropoietin	B:C0014822
(	O
erythropoietin	O
)	O
has	O
been	O
demonstrated	O
to	O
protect	O
against	O
chemotherapy	O
drug	O
doxorubicin	O
(	O
doxorubicin	O
)	O
-	O
induced	O
cardiotoxicity	O
,	O
but	O
the	O
underlying	O
mechanism	O
remains	O
obscure	O
.	O

The	O
hormone	O
erythropoietin	O
(	O
erythropoietin	B:C0014822
)	O
has	O
been	O
demonstrated	O
to	O
protect	O
against	O
chemotherapy	O
drug	O
doxorubicin	O
(	O
doxorubicin	O
)	O
-	O
induced	O
cardiotoxicity	O
,	O
but	O
the	O
underlying	O
mechanism	O
remains	O
obscure	O
.	O

The	O
hormone	O
erythropoietin	O
(	O
erythropoietin	O
)	O
has	O
been	O
demonstrated	O
to	O
protect	O
against	O
chemotherapy	B:C3665472
drug	O
doxorubicin	O
(	O
doxorubicin	O
)	O
-	O
induced	O
cardiotoxicity	O
,	O
but	O
the	O
underlying	O
mechanism	O
remains	O
obscure	O
.	O

The	O
hormone	O
erythropoietin	O
(	O
erythropoietin	O
)	O
has	O
been	O
demonstrated	O
to	O
protect	O
against	O
chemotherapy	O
drug	B:C0013227
doxorubicin	O
(	O
doxorubicin	O
)	O
-	O
induced	O
cardiotoxicity	O
,	O
but	O
the	O
underlying	O
mechanism	O
remains	O
obscure	O
.	O

The	O
hormone	O
erythropoietin	O
(	O
erythropoietin	O
)	O
has	O
been	O
demonstrated	O
to	O
protect	O
against	O
chemotherapy	O
drug	O
doxorubicin	B:C0013089
(	O
doxorubicin	O
)	O
-	O
induced	O
cardiotoxicity	O
,	O
but	O
the	O
underlying	O
mechanism	O
remains	O
obscure	O
.	O

The	O
hormone	O
erythropoietin	O
(	O
erythropoietin	O
)	O
has	O
been	O
demonstrated	O
to	O
protect	O
against	O
chemotherapy	O
drug	O
doxorubicin	O
(	O
doxorubicin	B:C0013089
)	O
-	O
induced	O
cardiotoxicity	O
,	O
but	O
the	O
underlying	O
mechanism	O
remains	O
obscure	O
.	O

The	O
hormone	O
erythropoietin	O
(	O
erythropoietin	O
)	O
has	O
been	O
demonstrated	O
to	O
protect	O
against	O
chemotherapy	O
drug	O
doxorubicin	O
(	O
doxorubicin	O
)	O
-	O
induced	O
cardiotoxicity	B:C0876994
,	O
but	O
the	O
underlying	O
mechanism	O
remains	O
obscure	O
.	O

We	O
hypothesized	O
that	O
silent	B:C1101544
mating	I:C1101544
type	I:C1101544
information	I:C1101544
regulation	I:C1101544
2	I:C1101544
homolog	I:C1101544
1	I:C1101544
(	O
SIRT1	O
)	O
,	O
an	O
NAD	O
(	I:C1101544
+	I:C1101544
)	I:C1101544
-	I:C1101544
dependent	I:C1101544
protein	I:C1101544
deacetylase	I:C1101544
that	O
activates	O
peroxisome	O
proliferator	I:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
(	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
)	O
,	O
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
mitochondrial	O
function	O
and	O
mediating	O
the	O
beneficial	O
effect	O
of	O
erythropoietin	O
.	O

We	O
hypothesized	O
that	O
silent	O
mating	I:C1101544
type	I:C1101544
information	I:C1101544
regulation	I:C1101544
2	I:C1101544
homolog	I:C1101544
1	I:C1101544
(	O
SIRT1	B:C1101544
)	O
,	O
an	O
NAD	O
(	I:C1101544
+	I:C1101544
)	I:C1101544
-	I:C1101544
dependent	I:C1101544
protein	I:C1101544
deacetylase	I:C1101544
that	O
activates	O
peroxisome	O
proliferator	I:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
(	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
)	O
,	O
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
mitochondrial	O
function	O
and	O
mediating	O
the	O
beneficial	O
effect	O
of	O
erythropoietin	O
.	O

We	O
hypothesized	O
that	O
silent	O
mating	I:C1101544
type	I:C1101544
information	I:C1101544
regulation	I:C1101544
2	I:C1101544
homolog	I:C1101544
1	I:C1101544
(	O
SIRT1	O
)	O
,	O
an	O
NAD	B:C1101544
(	I:C1101544
+	I:C1101544
)	I:C1101544
-	I:C1101544
dependent	I:C1101544
protein	I:C1101544
deacetylase	I:C1101544
that	O
activates	O
peroxisome	O
proliferator	I:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
(	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
)	O
,	O
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
mitochondrial	O
function	O
and	O
mediating	O
the	O
beneficial	O
effect	O
of	O
erythropoietin	O
.	O

We	O
hypothesized	O
that	O
silent	O
mating	I:C1101544
type	I:C1101544
information	I:C1101544
regulation	I:C1101544
2	I:C1101544
homolog	I:C1101544
1	I:C1101544
(	O
SIRT1	O
)	O
,	O
an	O
NAD	O
(	I:C1101544
+	I:C1101544
)	I:C1101544
-	I:C1101544
dependent	I:C1101544
protein	I:C1101544
deacetylase	I:C1101544
that	O
activates	O
peroxisome	B:C1452082
proliferator	I:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
(	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
)	O
,	O
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
mitochondrial	O
function	O
and	O
mediating	O
the	O
beneficial	O
effect	O
of	O
erythropoietin	O
.	O

We	O
hypothesized	O
that	O
silent	O
mating	I:C1101544
type	I:C1101544
information	I:C1101544
regulation	I:C1101544
2	I:C1101544
homolog	I:C1101544
1	I:C1101544
(	O
SIRT1	O
)	O
,	O
an	O
NAD	O
(	I:C1101544
+	I:C1101544
)	I:C1101544
-	I:C1101544
dependent	I:C1101544
protein	I:C1101544
deacetylase	I:C1101544
that	O
activates	O
peroxisome	O
proliferator	I:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
(	O
proliferator	B:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
)	O
,	O
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
mitochondrial	O
function	O
and	O
mediating	O
the	O
beneficial	O
effect	O
of	O
erythropoietin	O
.	O

We	O
hypothesized	O
that	O
silent	O
mating	I:C1101544
type	I:C1101544
information	I:C1101544
regulation	I:C1101544
2	I:C1101544
homolog	I:C1101544
1	I:C1101544
(	O
SIRT1	O
)	O
,	O
an	O
NAD	O
(	I:C1101544
+	I:C1101544
)	I:C1101544
-	I:C1101544
dependent	I:C1101544
protein	I:C1101544
deacetylase	I:C1101544
that	O
activates	O
peroxisome	O
proliferator	I:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
(	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
)	O
,	O
plays	O
a	O
crucial	O
role	O
in	O
regulating	O
mitochondrial	O
function	O
and	O
mediating	O
the	O
beneficial	O
effect	O
of	O
erythropoietin	B:C0014822
.	O

Our	O
study	B:C2603343
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	B:C0086418
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	B:C0225828
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	B:C0682523
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	B:C0013089
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	B:C0596402
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	B:C4021734
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	B:C0012929
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	B:C0012929
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	B:C1720920
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	B:C1743497
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	B:C4055506
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	O
pretreatment	O
.	O

Our	O
study	O
in	O
human	O
cardiomyocyte	O
AC16	O
cells	I:C0682523
showed	O
that	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
mitochondrial	O
dysfunction	I:C4021734
,	O
as	O
manifested	O
by	O
decreased	O
mitochondrial	O
DNA	I:C0012929
(	O
mitochondrial	O
DNA	I:C0012929
)	O
copy	O
number	O
,	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
,	O
and	O
increased	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
can	O
be	O
mitigated	O
by	O
erythropoietin	B:C0014822
pretreatment	O
.	O

erythropoietin	B:C0014822
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	B:C0041904
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	B:C1101544
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	B:C1171362
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	B:C0013089
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	B:C1521754
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	B:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	B:C0038855
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	B:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	B:C0017337
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	B:C1565068
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	B:C1565068
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	B:C0965025
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	B:C0965025
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	B:C0008855
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	B:C0008855
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	B:C0968147
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	B:C0968147
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	B:C0010760
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	B:C0010760
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	B:C1506024
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

erythropoietin	O
was	O
found	O
to	O
upregulate	O
SIRT1	O
activity	O
and	O
protein	O
expression	I:C1171362
to	O
reverse	O
doxorubicin	O
-	O
induced	O
acetylation	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
suppression	O
of	O
a	O
suite	O
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
-	O
activated	O
genes	O
involved	O
in	O
mitochondrial	O
function	O
and	O
biogenesis	O
,	O
such	O
as	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
(	O
nuclear	O
respiratory	I:C1565068
factor	I:C1565068
-	I:C1565068
1	I:C1565068
)	O
,	O
mitochondrial	O
transcription	I:C0965025
factor	I:C0965025
A	I:C0965025
(	O
TFAM	O
)	O
,	O
citrate	O
synthase	I:C0008855
(	O
citrate	O
synthase	I:C0008855
)	O
,	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
(	O
superoxide	O
dismutase	I:C0968147
2	I:C0968147
)	O
,	O
cytochrome	O
c	I:C0010760
oxidase	I:C0010760
IV	I:C0010760
(	O
c	O
oxidase	I:C0010760
IV	I:C0010760
)	O
,	O
and	O
voltage	O
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
(	O
voltage	B:C1506024
-	I:C1506024
dependent	I:C1506024
anion	I:C1506024
channel	I:C1506024
)	O
.	O

Silencing	B:C0598496
of	O
SIRT1	O
via	O
small	O
RNA	O
interference	I:C1136031
sensitized	O
AC16	I:C0312864
cells	I:C0312864
to	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
reduction	O
in	O
mitochondrial	O
DNA	I:C0012929
copy	O
number	O
.	O

Silencing	O
of	O
SIRT1	B:C1423062
via	O
small	O
RNA	O
interference	I:C1136031
sensitized	O
AC16	I:C0312864
cells	I:C0312864
to	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
reduction	O
in	O
mitochondrial	O
DNA	I:C0012929
copy	O
number	O
.	O

Silencing	O
of	O
SIRT1	O
via	O
small	O
RNA	B:C1136031
interference	I:C1136031
sensitized	O
AC16	I:C0312864
cells	I:C0312864
to	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
reduction	O
in	O
mitochondrial	O
DNA	I:C0012929
copy	O
number	O
.	O

Silencing	O
of	O
SIRT1	O
via	O
small	O
RNA	O
interference	I:C1136031
sensitized	B:C0312864
AC16	I:C0312864
cells	I:C0312864
to	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
reduction	O
in	O
mitochondrial	O
DNA	I:C0012929
copy	O
number	O
.	O

Silencing	O
of	O
SIRT1	O
via	O
small	O
RNA	O
interference	I:C1136031
sensitized	O
AC16	I:C0312864
cells	I:C0312864
to	O
doxorubicin	B:C0013089
-	O
induced	O
cytotoxicity	O
and	O
reduction	O
in	O
mitochondrial	O
DNA	I:C0012929
copy	O
number	O
.	O

Silencing	O
of	O
SIRT1	O
via	O
small	O
RNA	O
interference	I:C1136031
sensitized	O
AC16	I:C0312864
cells	I:C0312864
to	O
doxorubicin	O
-	O
induced	O
cytotoxicity	B:C0596402
and	O
reduction	O
in	O
mitochondrial	O
DNA	I:C0012929
copy	O
number	O
.	O

Silencing	O
of	O
SIRT1	O
via	O
small	O
RNA	O
interference	I:C1136031
sensitized	O
AC16	I:C0312864
cells	I:C0312864
to	O
doxorubicin	O
-	O
induced	O
cytotoxicity	O
and	O
reduction	O
in	O
mitochondrial	B:C0012929
DNA	I:C0012929
copy	O
number	O
.	O

Although	O
with	O
SIRT1	B:C1423062
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	B:C0598496
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	B:C0014822
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	B:C0013089
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	B:C1743497
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	B:C4055506
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	B:C1720920
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	B:C0001480
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	B:C1171362
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	B:C1452082
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	B:C0522506
genes	O
.	O

Although	O
with	O
SIRT1	O
silenced	O
,	O
erythropoietin	O
could	O
reverse	O
to	O
some	O
extent	O
doxorubicin	O
-	O
induced	O
mitochondrial	O
superoxide	I:C1743497
accumulation	O
,	O
loss	O
of	O
mitochondrial	O
membrane	I:C1720920
potential	I:C1720920
and	O
ATP	O
depletion	O
,	O
it	O
failed	O
to	O
normalize	O
protein	O
expression	I:C1171362
of	O
proliferator	O
-	I:C1452082
activated	I:C1452082
receptor	I:C1452082
gamma	I:C1452082
coactivator	I:C1452082
1	I:C1452082
-	I:C1452082
alpha	I:C1452082
and	O
its	O
downstream	O
genes	B:C0017337
.	O

Taken	O
together	O
,	O
our	O
results	O
indicated	O
that	O
erythropoietin	B:C0014822
may	O
activate	O
SIRT1	O
to	O
enhance	O
mitochondrial	O
function	O
and	O
protect	O
against	O
doxorubicin	O
-	O
induced	O
cardiotoxicity	O
.	O

Taken	O
together	O
,	O
our	O
results	O
indicated	O
that	O
erythropoietin	O
may	O
activate	O
SIRT1	B:C2720167
to	O
enhance	O
mitochondrial	O
function	O
and	O
protect	O
against	O
doxorubicin	O
-	O
induced	O
cardiotoxicity	O
.	O

Taken	O
together	O
,	O
our	O
results	O
indicated	O
that	O
erythropoietin	O
may	O
activate	O
SIRT1	O
to	O
enhance	O
mitochondrial	O
function	O
and	O
protect	O
against	O
doxorubicin	B:C0013089
-	O
induced	O
cardiotoxicity	O
.	O

Taken	O
together	O
,	O
our	O
results	O
indicated	O
that	O
erythropoietin	O
may	O
activate	O
SIRT1	O
to	O
enhance	O
mitochondrial	O
function	O
and	O
protect	O
against	O
doxorubicin	O
-	O
induced	O
cardiotoxicity	B:C0876994
.	O

